Sinae APIs Categoria Factory

Active Pharmaceutical Ingredientia

Progestogen et Estrogen
Product Name	Specification	Probatus	CAS Non.
Progesterone	CP/EP/USP	CEP/EU-GMP/FDA	57-83-0
Pregnenolone	In domo	Kosher	145-13-1
Medroxyprogesterone Acetate	CP/EP/USP	DMF/GMP	71-58-9
Megestrol acetate	CP/EP/USP	DMF in processusususus	595-33-5
Mifepristone	CP/IP	DMF/GMP	84371-65-3
Cyproterone Acetate	CP/EP	CEP/TGA/EU-GMP	427-51-0
Levonorgestrel	CP/EP/USP	CEP/GMP	797-63-7
Drospirenone	EP/USP	DMF	67392-87-4
Gestodene	CP/EP	DMF/GMP	60282-87-3
Estradiol	CP/EP/USP	DMF/GMP	35380-71-3
Estriol	CP/EP/USP	Sub R&D	50-27- 1
Ethinyl Estradiol	CP/EP/USP	GMP	57-63-6
Estradiol Valerate	CP	DMF	979-32-8
Tibolone	CP/EP	DMF/GMP	5630-53-5
Dienogest	EP	CEP	65928-58-7
Fulvestrant	In domo	Sub R&D	129453-61-8
Exemestane	EP/USP	Sub R&D	107868-30-4

Androgen
Product Name	Specification	Probatus	CAS Non.
Finasteride	CP/EP/USP	CEP/FDA/PMDA/GMP	98319-26-7
Dutasteride	EP/USP	CEP/FDA	164656-23-9
Abiraterone Acetate	CP/USP	DMF/WC	154229-18-2
Testosterone	CP/EP/USP	CEP/WC/FDA	58-22-0
Testosterone Undecanoate	CP	DMF/WC	5949-44-0
Testosterone Cypionate	USP	Sub R&D	58-20-8
DHEA(Prasterone)	FP/In domo	DMF/WC/Kosher	53-43-0
Clascoterone	In domo	DMF in processusususus	19608-29-8

Cortical Hormone
Product Name	Specification	Probatus	CAS Non.
Budesonide	CP/EP/USP	CEP/FDA/GMP	51333-22-3
Desonide	USP	DMF/GMP	638-94-8
Eplerenone	EP	CEP in processu	107724-20-9
Methylprednisolone	CP/EP/USP	DMF/GMP	83-43-2
Methylprednisolone Hemisuccinate	CP/EP/USP	DMF/GMP	2921-57-5
Fluticasone Propionate	CP/EP/USP	DMF	80474- 14-2
Fluticasone Furoate	In domo	DMF in processusususus	397864-44-7
Mometasone Furoate	EP/USP	DMF in processusususus	Anhydrous (83919-23-7) Monohydratorum (141646-00-6)

alii
Product Name	Specification	Probatus	CAS Non.
Oxcarbazepine	CP/EP/USP	CEP/FDA	28721-07-5
Eslicarbazepine Acetate	In domo	DMF	236395- 14-5
Ganciclovir	CP/EP/USP	DMF/GMP	82410-32-0
Valganciclovir Hydrochloride	USP	DMF	175865-59-5
Oseltamivir Phosphate	CP/EP/USP	DMF	204255- 11-8
Baloxavir Marboxil	In domo	Sub R&D	1985606-14-1
Nintedanib Esylate	In domo	DMF/FDA	656247-18-6
Revefenacin	In domo	DMF	864750-70-9
Mirabegron	In domo	DMF	223673-61-8
Escitalopram Oxalate	EP/USP/CP	DMF in processususus	219861-08-2
Cariprazine hydrochloride	In domo	DMF	1083076-69-0
Lasmiditan Succinate	In domo	DMF	439239-92-6
Iuliconazole	In domo	DMF	187164-19-8
Apalutami	In domo	DMF in processususus	956104-40-8
Tadalafil	EP/USP/CP	Sub R&D	171596-29-5
Relugolix	In domo	DMF in processususus	737789-87-6
Phloroglucinol	CP	DMF	108-73-6
Acidum Ursodeoxycholic	EP/USP/JP	Sub R&D	128-13-2
Omega-3-Acid Ethyl Ethers 90	EP/USP	DMF in processusususus	--
Medium-Chain Triglycerides	CP/USP/EP	DMF	--
Benzalkonium Chloride	USP/EP/JP	CEP in processu	8001-54-5
Oleum olivae (For Iniectio)	CP/USP/EP/JP	DMF in processusususus	8001-25-0
Ovum phospholipids (Nam Iniectio)	CP/USP/EP	DMF	93685-90-6
PORTIO	In domo	DMF in processusususus	203787-91-1

View as

Lasmiditan Succinate

Lasmiditan Succinatus habet specificationem In-domus. DMF probatus.

CAS:439239-92-6

Lege plus Mitte Inquisitionem

Cariprazinum hydrochloridum

Cariprazinum hydrochloridum in specificatione-domum habet. DMF probatus.

CAS: 1083076-69-0

Lege plus Mitte Inquisitionem

Mirabegron

Mirabegron habet specificationem in domo. DMF probatus est.,.

CAS:223673-61-8

Lege plus Mitte Inquisitionem

Fulvestrant

Fulvestrant EP et USP specificationes habet.

CAS:129453-61-8

Lege plus Mitte Inquisitionem

Iuliconazole

Luliconazole habet specificationem In-domum, DMF sub interpositione.

CAS:187164-19-8

Lege plus Mitte Inquisitionem

<...3 4 5 6 7 >

Humanwell Pharmaceuticus unus ex maximis API fabricandis in Sinis. Cum plusquam XX annos experientiae, APIs, intermediis et formulis elaboramus, fabricamus et mercaturas steroidales. Forum nostrum toto orbe terrarum operit, praesentias validas habemus in America Septentrionali, Europa, America Meridionali et Africa, cum fructibus plus quam 150 terris venditis.